Outcomes of bacteremia in patients with cancer and neutropenia: Observations from two decades of epidemiological and clinical trials

Clinical Infectious Diseases

Volumn 25, Issue 2, 1997, Pages 247-259

  Elting, Linda S ^a   Rubenstein, Edward B ^a   Rolston, Kenneth V I ^a   Bodey, Gerald P ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFOPERAZONE; CEFTAZIDIME; CIPROFLOXACIN; COLONY STIMULATING FACTOR; COTRIMOXAZOLE; IMIPENEM; LATAMOXEF; PIPERACILLIN; SULPERAZON; TIMENTIN; TOBRAMYCIN; VANCOMYCIN;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; CANCER PATIENT; CLINICAL TRIAL; CLOSTRIDIUM; COST EFFECTIVENESS ANALYSIS; HUMAN; LEUKOCYTE COUNT; MORTALITY; NEUTROPENIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PSEUDOMONAS; SEPTIC SHOCK; TREATMENT OUTCOME;

EID: 0030858393     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/514550     Document Type: Article

References (26)

1. Bodey GP, Jadeja L, Elting L. Pseudomonas bacteremia - retrospective analysis of 410 episodes. Arch Intern Med 1985; 145:1621-9.
2. Rolston K, Guan Z, Bodey GP, Elting L. Acinetobacter calcoaceticus septicemia in patients with cancer. South Med J 1985; 78:647-51.
3. Bodey GP, Elting L, Kassamali H, Lim BP. Escherichia coli bacteremia in cancer patients. Am J Med 1986;81(suppl 1A):85-95.
4. Elting LS, Bodey GP, Fainstein V. Polymicrobial septicemia in the cancer patient. Medicine (Baltimore) 1986; 65:218-25.
5. Fainstein V, Berkey P, Elting L, Bodey GP. Haemophilus species bacteremia in patients with cancer. A 13-year experience. Arch Intern Med 1989; 149:1341-5.
6. Bodey GP, Elting LS, Rodriguez S, Hernandez M. Klebsiella bacteremia: a 10-year review in a cancer institution. Cancer 1989; 64:2368-76.
7. Bodey GP, Elting LS, Rodriguez S. Bacteremia caused by Enterobacter: 15 years of experience in a cancer hospital. Rev Infect Dis 1991; 13:550-8.
8. Fainstein V, Elting LS, Bodey GP. Bacteremia caused by non-sporulating anaerobes in cancer patients. A 12-year experience. Medicine (Baltimore) 1989; 68:151-62.
9. Saito H, Elting LS, Bodey GP, Berkey P. Serratia bacteremia: review of 118 cases. Rev Infect Dis 1989; 11:912-20.
10. Elting LS, Bodey GP. Septicemia due to Xanthomonas species and non-aeruginosa Pseudomonas species: increasing incidence of catheter-related infections. Medicine (Baltimore) 1990;69:296-306.
11. Bodey GP, Rodriguez S, Fainstein V, Elting LS. Clostridial bacteremia in cancer patients - a 12-year experience. Cancer 1991; 67:1928-42.
12. Samonis G, Anaissie E, Elting L, Bodey GP. Review of Citrobacter bacteremia in cancer patients over a sixteen-year period. Eur J Clin Microbiol Infect Dis 1991; 10:479-85.
13. Elting LS, Bodey GP, Keefe BH. Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors. Clin Infect Dis 1992; 14:1201-7.
14. Fainstein V, Bodey GP, Elting L, et al. A randomized study of ceftazidime compared to ceftazidime and tobrarnycin for the treatment of infections in cancer patients. J Antimicrob Chemother 1983; 12(suppl A):101-10.
15. Fainstein V, Bodey GP, Bolivar R, et al. Moxalactam plus ticarcillin or tobramycin for treatment of febrile episodes in neutropenic cancer patients. Arch Intern Med 1984; 144:1766-70.
16. Jones PG, Rolston KVI, Fainstein V, Elting L, Walters RS, Bodey GP. Aztreonam therapy in neutropenic patients with cancer. Am J Med 1986; 81:243-8.
17. Anaissie EJ, Fainstein V, Bodey GP, et al. Randomized trial of beta-lactam regimens in febrile neutropenic cancer patients. Am J Med 1988; 84:581-9.
18. Bodey GP, Fainstein V, Elting LS, et al. β-Lactam regimens for the febrile neutropenic patient. Cancer 1990;65:9-16.
19. Rolston KVI, Berkey P, Bodey GP, et al. A comparison of imipenem to ceftazidime with or without amikacin as empiric therapy in febrile neutropenic patients. Arch Intern Med 1992; 152:283-91.
20. Bodey G, Reuben A, Elting L, et al. Comparison of two schedules of cefoperazone plus aztreonam in the treatment of neutropenic patients with fever. Eur J Clin Microbiol Infect Dis 1991; 10:551-8.
21. Bodey GP, Elting LS, Narro J, et al. An open trial of cefoperazone plus sulbactam for the treatment of fever in cancer patients. J Antimicrob Chemother 1993; 32:141-52.
22. Raad II, Whimbey EE, Rolston KVI, et al. A comparison of aztreonam plus vancomycin and imipenem plus vancomycin as initial therapy for febrile neutropenic cancer patients. Cancer 1996; 77:1386-94.
23. Anaissie EJ, Vartivarian S, Bodey GP, et al. Randomized comparison between antibiotics alone and antibiotics plus granulocyte-macrophage colony stimulating factor (E-coli derived) in cancer patients with fever and neutropenia. Am J Med 1996; 100:17-23.
24. Cowan ST, Steele KJ. Manual of identification of medical bacteria. London: Cambridge University Press, 1965.
25. Bauer AW, Kirby WMM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 1966; 45:493-6.
26. Pizzo PA, Armstrong D, Bodey G, et al. The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient: report of a consensus panel. J Infect Dis 1990; 161:397-401.